BSE: 0 | NSE: AATMAJ | Hospital & Healthcare Services | Small Cap
Past 10 year's financial track record analysis by Moneyworks4me indicates that Aatmaj Healthcare Ltd is a average quality company.
The key valuation ratios of Aatmaj Healthcare Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Aatmaj Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|
| ROCE % ⓘ | 4.2% | 63.8% | 67.5% | 46.6% | 6.4% | - |
| Value Creation Index ⓘ | NA | 3.6 | 3.8 | 2.3 | -0.5 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | ||||||
| Sales ⓘ | 4.4 | 17.3 | 21.8 | 27.2 | 15.7 | 16 |
| Sales YoY Gr. | - | 295.9% | 26.4% | 24.5% | -42.1% | - |
| Adj EPS ⓘ | -0.2 | 2.5 | 3.1 | 3.7 | 0.4 | 0.4 |
| YoY Gr. | - | NA | 22.8% | 17% | -89.3% | - |
| BVPS (₹) ⓘ | -0.6 | 2 | 5.1 | 8.8 | 21.9 | 21.9 |
| Adj Net Profit ⓘ | -0.3 | 4.1 | 5.1 | 5.9 | 0.9 | 1 |
| Cash Flow from Ops. ⓘ | -0.5 | 6.1 | 9.6 | 5.3 | -8 | - |
| Debt/CF from Ops. ⓘ | -16.3 | 0.7 | 0.5 | 2.2 | -0.7 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | -3% | -42.1% | ||||
| Adj EPS ⓘ | NA | NA | -46.5% | -89.3% | ||||
| BVPSⓘ | NA | NA | 123.2% | 150.2% | ||||
| Share Price | - | - | - | -37.3% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 29 | 365.6 | 88.2 | 52.6 | 2.8 | 1.8 |
| Op. Profit Mgn % ⓘ | 15.5 | 30.6 | 34.4 | 36.2 | 16.2 | NAN |
| Net Profit Mgn % ⓘ | -6.2 | 23.9 | 23.2 | 21.8 | 5.6 | 5.6 |
| Debt to Equity ⓘ | -9.4 | 1.4 | 0.6 | 0.8 | 0.1 | - |
| Working Cap Days ⓘ | 0 | 25 | 62 | 174 | 559 | 0 |
| Cash Conv. Cycle ⓘ | 0 | -30 | 2 | 101 | 388 | 0 |
Debt to equity has declined versus last 3 years average to 0.11
Return on Equity has declined versus last 3 years average to 1.80%
Sales growth has been subdued in last 3 years -3.03%
Net Profit has been subdued in last 3 years -46.45%
Sales growth is not so good in last 4 quarters at 0.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 0.4 | 2.2 |
| TTM Sales (₹ Cr.) | 15.7 | 21.8 |
| BVPS (₹.) ⓘ | 21.9 | 5 |
| Reserves (₹ Cr.) ⓘ | 38 | - |
| P/BV ⓘ | 1.15 | 5.02 |
| PE ⓘ | 64.40 | 11.53 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 0.00 / 0.00 |
| All Time Low / High (₹) | - / - |
| Market Cap (₹ Cr.) | 56.7 |
| Equity (₹ Cr.) | 11.3 |
| Face Value (₹) | 5 |
| Industry PE ⓘ | 43.2 |
| Pledged * | 0.00 | 0.00 | 0.00 |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|
| Sales | 4.36 | 17.26 | 21.81 | 27.16 | 15.74 |
| Operating Expenses ⓘ | 3.68 | 11.97 | 14.30 | 17.33 | 13.18 |
| Manufacturing Costs | 0.67 | 3.99 | 3.79 | 4.58 | 1.95 |
| Material Costs | 0.78 | 4.17 | 3.67 | 1.74 | 2.46 |
| Employee Cost | 0.68 | 1.54 | 3.94 | 4.66 | 3.57 |
| Other Costs ⓘ | 1.54 | 2.28 | 2.89 | 6.36 | 5.20 |
| Operating Profit ⓘ | 0.68 | 5.29 | 7.51 | 9.83 | 2.55 |
| Operating Profit Margin (%) | 15.5% | 30.6% | 34.4% | 36.2% | 16.2% |
| Other Income ⓘ | 0.01 | 0 | 0 | 0.03 | 0.85 |
| Interest ⓘ | 0.50 | 0.44 | 0.24 | 0.90 | 1.25 |
| Depreciation ⓘ | 0.36 | 0.39 | 0.43 | 0.69 | 0.81 |
| Exceptional Items ⓘ | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax ⓘ | -0.18 | 4.46 | 6.83 | 8.27 | 1.34 |
| Tax ⓘ | 0.09 | 0.34 | 1.78 | 2.37 | 0.46 |
| Profit After Tax | -0.27 | 4.12 | 5.05 | 5.91 | 0.88 |
| PAT Margin (%) | -6.2% | 23.9% | 23.2% | 21.7% | 5.6% |
| Adjusted EPS (₹) | -0.2 | 2.5 | 3.1 | 3.7 | 0.4 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 13% |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | -0.93 | 3.19 | 8.27 | 14.18 | 49.48 | |||||
| Share Capital ⓘ | 1.35 | 1.35 | 1.35 | 8.10 | 11.30 | |||||
| Reserves ⓘ | -2.28 | 1.84 | 6.92 | 6.08 | 38.18 | |||||
| Minority Interest | 0 | 0 | 0 | 0 | 0 | |||||
| Debt | 8.18 | 3.75 | 5.18 | 11.49 | 5.27 | |||||
| Long Term Debt | 6.72 | 3.28 | 0.72 | 1.79 | 1.24 | |||||
| Short Term Debt | 1.46 | 0.47 | 4.45 | 9.70 | 4.03 | |||||
| Trade Payables | 1.07 | 1.70 | 1.64 | 2.12 | 1.32 | |||||
| Others Liabilities ⓘ | 1.01 | 1.16 | 2.39 | 3.22 | 1.61 | |||||
| Total Liabilities ⓘ | 9.33 | 9.80 | 17.47 | 31.01 | 57.68 | |||||
Fixed Assets | ||||||||||
| Gross Block | 8.92 | 9.49 | 12.59 | 13.58 | 21.40 | |||||
| Accumulated Depreciation | 0.89 | 1.29 | 1.72 | 2.41 | 3.22 | |||||
| Net Fixed Assetsⓘ | 8.02 | 8.21 | 10.87 | 11.17 | 18.18 | |||||
| CWIP ⓘ | 0 | 0 | 0 | 0 | 0 | |||||
| Investmentsⓘ | 0 | 0 | 0 | 0 | 0 | |||||
| Inventories | 0.14 | 0.21 | 0.41 | 0.40 | 0.64 | |||||
| Trade Receivables | 0.98 | 0.57 | 5.10 | 17.83 | 20.62 | |||||
| Cash Equivalents | 0.02 | 0.55 | 0.18 | 0.32 | 10.81 | |||||
| Others Assetsⓘ | 0.16 | 0.27 | 0.91 | 1.29 | 7.44 | |||||
| Total Assets ⓘ | 9.33 | 9.80 | 17.47 | 31.01 | 57.68 | |||||
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | -0.54 | 6.11 | 9.55 | 5.33 | -8.01 |
| PBT ⓘ | -0.18 | 4.46 | 6.83 | 8.27 | 1.34 |
| Adjustment ⓘ | 0.87 | 0.83 | 0.68 | 1.58 | 2.06 |
| Changes in Working Capital ⓘ | -1.22 | 1.07 | 0.29 | -6.72 | -11.73 |
| Tax Paid ⓘ | 0 | -0.25 | 1.75 | 2.19 | 0.32 |
| Cash Flow From Investing Activity ⓘ | -0.18 | -0.71 | -3.37 | -1.42 | -7.82 |
| Capex | -0.18 | -0.57 | -3.10 | -0.98 | -7.82 |
| Net Investments | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | 0 | -0.14 | -0.26 | -0.43 | 0 |
| Cash Flow From Financing Activityⓘ | 0.67 | -4.87 | -6.55 | -3.78 | 26.32 |
| Net Proceeds from Shares ⓘ | 0.27 | 0 | 0 | 0 | 34.32 |
| Net Proceeds from Borrowing ⓘ | 0.90 | -3.44 | 0 | 0 | 0 |
| Interest Paid ⓘ | -0.50 | -0.44 | 0 | 0 | -1.25 |
| Dividend Paid ⓘ | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | 0 | -0.99 | -6.55 | -3.78 | -6.76 |
| Net Cash Flow ⓘ | -0.05 | 0.53 | -0.37 | 0.14 | 10.49 |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | N/A | 365.56 | 88.15 | 52.62 | 2.77 | |||||
| ROCE (%) | N/A | 63.84 | 67.49 | 46.63 | 6.41 | |||||
| Asset Turnover Ratio | 0.47 | 1.8 | 1.6 | 1.12 | 0.35 | |||||
| PAT to CFO Conversion(x) | N/A | 1.48 | 1.89 | 0.9 | -9.1 | Working Capital Days | ||||
| Receivable Days | 82 | 16 | 47 | 154 | 446 | |||||
| Inventory Days | 12 | 4 | 5 | 5 | 12 | |||||
| Payable Days | 498 | 121 | 166 | 394 | 255 | |||||
The company was originally incorporated on March 10, 2014 as ‘Aatmaj Healthcare Private Limited’, under the provisions of the Companies Act, 1956 vide certificate of incorporation dated March 10, 2014 issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli. The company was formed by promoters namely Dr. Tushar Suvagiya and Dr. Subhash Padmani with the main object as, and presently engaged in the business, to run nursing homes and healthcare centers, for the reception and treatment of persons suffering from illness or of persons requiring medicinal attention or rehabilitation and to provide medical relief in all branches of medical sciences etc. Dr. Ravi Apte joined the company as Director in the month of April 2015. The company was converted into a Public Limited Company pursuant to the special resolution passed by the shareholders at the extraordinary general meeting of the company held on November 16, 2022 and consequent upon conversion the name of the company was changed to ‘Aatmaj Healthcare Limited’ vide a fresh certificate of incorporation dated December 6, 2022 issued by the Registrar of Companies, Ahmedabad.
The company is a growing organization that aims at strengthening and establishing it’s self as the foremost healthcare services provider. It strives to serve with its ultra-modern medicinal practices and state of the art infrastructure for medical as well as surgical care solutions. It aims towards continuous improvement of its healthcare facilities and to achieve the level of care and quality, it has constituted committees such as Quality Assurance and Safety Committee, Infection Control Committee, CPR Committee, Pharmacy and Therapeutic Committee, Blood Transfusion Committee, Committee for Medical Records and Women’s Safety Committee. It has a team of medical practitioners who ensures that patients get the quality healthcare services. Its dedicated team is trained to take care of the patients and handle health related emergencies. Its healthcare staff members comprise of Unit Head, Consultant Doctors, Clinical Pharmacist, X-Ray Technician, Microbiologist, Medical Officers, Clinical Assistants, Medical Executives, OT Assistant, Infection Control Nurse, Other Nursing Staff, Attendants, Maintenance Head, Dietician/Nutritionist etc.
It is a part of Ayushman Bharat-Pradhan Mantri Jan ArogyaYojana, a flagship scheme of Government of India which was launched and recommended by the National Health Policy 2017, to achieve the vision of universal health coverage (UHC). The initiative has been designed on the lines as to meet SDG and its underlining commitment. Ayushman Bharat is an attempt to move from sectoral and segmented approach of health service delivery to a comprehensive need-based health care service and Mukhyamantri Amrutam (MA) scheme is launched by Gujarat state to cater families below the poverty line.
Business area of the company
The company is a growing organization that aims at strengthening and establishing it’s self as the foremost healthcare services provider. It strives to serve with its ultra-modern medicinal practices and state of the art infrastructure for medical as well as surgical care solutions.
Services of the company
History and milestone
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Limited to the first 10 users today!
Practical Stock Investing Hand Book
By - Raymond Moses
Founder of MoneyWorks4Me | Consultant | Trainer | Author | TEDx Speaker
Register & Get Instant Access!Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
